Home > Insider Trading > Filing (0001181431-14-004179)

Filing Details

Accession Number:: 0001181431-14-004179
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-01-28 17:39:36
Reporting Period:: 2014-01-27

Filing Date:: 2014-01-28
Accepted Time:: 2014-01-28 17:39:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1011835	Medivation Inc.	MDVN	Pharmaceutical Preparations (2834)	133863260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1310880	David Hung	C/O Medivation, Inc. 525 Market St., 36Th Floor San Francisco CA 94105	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-01-27	150,000	$5.88	1,100,204	No	4	M	Direct
Common Stock	Disposition	2014-01-27	11,000	$71.77	1,089,204	No	4	S	Direct
Common Stock	Disposition	2014-01-27	61,823	$72.99	1,027,381	No	4	S	Direct
Common Stock	Disposition	2014-01-27	62,577	$73.72	964,804	No	4	S	Direct
Common Stock	Disposition	2014-01-27	1,700	$74.75	963,104	No	4	S	Direct
Common Stock	Disposition	2014-01-27	9,900	$76.15	953,204	No	4	S	Direct
Common Stock	Disposition	2014-01-27	3,000	$76.43	950,204	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2014-01-27	300,000	$0.00	300,000	$5.88

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
50,000		2016-10-31	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	86,060	Indirect	By trust

Footnotes

Shares sold pursuant to a 10b5-1 Plan.
The shares were sold at prices ranging from $71.27 to $72.24. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $72.31 to $73.305. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $73.32 to $74.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $74.34 to $75.34. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $75.385 to $76.38. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $76.40 to $76.46. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Fully vested.